ArticleJournal of parasitology research2026
Polymorphism of
Article in Journal of parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Polymorphism ofJournal of parasitology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malaria is one of the most devastating infectious diseases in humans, and antimalarial drugs have been used to combat it with minimal success. Worldwide, malaria treatment is threatened by the emergence and spread of artemisinin resistance, which is associated with mutations in the Methods: This cross-sectional study enrolled all participants presenting with fever at GRRH between April 2022 and January 2024. Data on adults and children aged ≥ 6 months with fever and confirmed diagnosis of malaria using mRDT, microscopy, and PCR were collected. Parasite DNA was extracted using the Chelex method and sequenced for multidrug resistance genes, and Sanger customized CRF forms were used to capture variables on social demographics, clinical presentation, and treatment. Data were analyzed using IBM SPSS Version 25, and the sequenced data were analyzed using molecular evolutionary genetic analysis (MEGA) Version 11.1.10. All sequences from a single population were aligned using the National Center for Biotechnology Information (NCBI) database. Results: In total, 353 participants were recruited, and the overall prevalence of Conclusion: The presence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.